evolcSign inStart free
Menu

Antineo

Preclinical oncology research services for pharmaceutical and biotech companies and academic institutions

Lyon, FranceFounded 2015antineo.frWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-02

About Antineo

Antineo is a contract research organization providing in vitro, ex vivo and in vivo preclinical oncology studies, including tumour models and immunology assays. Its work supports proof-of-concept research and evaluation of anticancer compounds.

Customers include private companies and academic institutions. Antineo is privately owned and was founded in 2015; it is based in Lyon, France, on the Lyon Est Bio-Health campus.

Product: Contract research services for preclinical oncology studies, including tumour models, immunology assays and in vitro, ex vivo and in vivo experiments.

Public tenders won

1 tender won since 1 Jan 2024 from 1 public buyer in France, worth €82k as awarded. From EU award notices (TED) that name Antineo by its registry number.

  • 1 Jul 2025 Universite de tours · Réalisation de prestations portant sur la bioconjugaison et l'évaluation in vivo de candidats médicaments de type ADCs dans le cadre du projet C-VALO/SNA Ab Omega · €82k notice

Open tenders like these →

Jobs at Antineo

No open positions listed right now.

Leadership

  • Renaud MARIN-SIDGWICK · Chief Executive Officer
    Source: company website
  • Marie TAUTOU · Study Director and Head of Business Development
    Source: company website

More biotech & pharma companies

  • Apmonia Therapeutics

    Develops peptide-based cancer therapies targeting the tumor microenvironment for patients with cancer
    Reims, FranceBiotech & pharmaFounded 2019
    New on Evolc

  • Aporepair

    Develops a therapeutic peptide for patients experiencing heart attacks
    Montpellier, FranceBiotech & pharmaFounded 2023
    Young companyNew on Evolc

  • Aqemia

    AI drug discovery company using physics-based algorithms and generative AI to design and optimise drug molecules
    Paris, FranceBiotech & pharmaFounded 201911 open jobs
    New on EvolcRemote-friendly

  • Astraveus

    Benchtop cell-processing systems for cell therapy developers and manufacturers
    Le Kremlin-Bicetre, FranceBiotech & pharmaFounded 2016
    New on Evolc

  • Atlanchim Pharma

    Custom synthesis and analytical chemistry services for pharmaceutical, biotech, cosmetics and other research organizations
    Saint-Herblain, FranceBiotech & pharmaFounded 2008
    New on Evolc

  • Atlantic Bone Screen

    Preclinical contract research services for pharmaceutical, biotech, biomaterials and nutraceutical developers
    Saint-Herblain, FranceBiotech & pharmaFounded 20051 open job
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Backend

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

CRM & customer data

  • HubSpotHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Contact Form 7High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WPFormsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.